These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5388566)

  • 1. Sulman FG: Mammotropic and neuroleptic effects of butyrophenones in the rat.
    Mishkinsky J; Khazen K; Givant Y; Dikstein S
    Arch Int Pharmacodyn Ther; 1969 May; 179(1):94-105. PubMed ID: 5388566
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacology of three mammotropic butyrophenones in the rat.
    Givant Y; Shani J; Goldhaber G; Serebrenik R; Sulman FG
    Arch Int Pharmacodyn Ther; 1973 Oct; 205(2):317-27. PubMed ID: 4797373
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of various neuroleptic drugs on shock avoidance responding in rats. II. Nondiscriminated Sidman avoidance procedure with alternate reinforcement and extinction periods and analysis of the interresponse times (IRT's).
    Niemegeers CJ; Verbruggen FJ; Janssen PA
    Psychopharmacologia; 1969; 16(3):175-82. PubMed ID: 5391696
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of various neuroleptic drugs on noise escape response in rats.
    Niemegeers CJ; Verbruggen FJ; Janssen PA
    Psychopharmacologia; 1970; 18(3):249-59. PubMed ID: 5530581
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological properties of a new potential neuroleptic drug oxyprothepin. I. The action on the central nervous system in rodents.
    Metysová J; Metys J
    Act Nerv Super (Praha); 1971; 13(3):185-6. PubMed ID: 5165408
    [No Abstract]   [Full Text] [Related]  

  • 6. Structure-activity-relationship of mammotropic phenothiazine derivaties.
    Khazen K; Mishkinsky J; Ben-David M; Sulman FG
    Arch Int Pharmacodyn Ther; 1968 Feb; 171(2):251-73. PubMed ID: 5693628
    [No Abstract]   [Full Text] [Related]  

  • 7. Intrastriatal injection of quaternary butyrophenones and oxypertine: neuroleptic effect in rats.
    Fog R; Randrup A; Pakkenberg H
    Psychopharmacologia; 1971; 19(3):224-30. PubMed ID: 5105727
    [No Abstract]   [Full Text] [Related]  

  • 8. 4'-Fluoro-4-(1,4,5,6-tetrahydroazepinol[4,5-b]indol-3(2H)-yl)butyrophenones.
    Hester JB; Rudzik AD; Keasling HH; Veldkamp W
    J Med Chem; 1970 Jan; 13(1):23-6. PubMed ID: 5460894
    [No Abstract]   [Full Text] [Related]  

  • 9. [The antipsychotic action of neuroleptics and basal ganglia function].
    Arushanian EB
    Farmakol Toksikol; 1973; 26(4):481-9. PubMed ID: 4151298
    [No Abstract]   [Full Text] [Related]  

  • 10. The nucleus amygdaloideus centralis and neuroleptic activity in the rat.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1974 Feb; 25(2):138-46. PubMed ID: 4154850
    [No Abstract]   [Full Text] [Related]  

  • 11. Prediction of neuroleptic effects from animal data.
    Vinar O; Krsiak M
    Adv Biochem Psychopharmacol; 1974; 9(0):675-83. PubMed ID: 4836228
    [No Abstract]   [Full Text] [Related]  

  • 12. Bromoperidol, a new potent neuroleptic of the butyrophenone series. Comparative pharmacology of bromoperidol and haloperidol.
    Niemegeers CJ; Janssen PA
    Arzneimittelforschung; 1974 Jan; 24(1):45-52. PubMed ID: 4406109
    [No Abstract]   [Full Text] [Related]  

  • 13. Dissociation between the mammotrophic and galactopoietic effects of perphenazine and perphenazine sulphoxide in the rat.
    Weller CP; Mishkinsky JS; Givant Y; Sulman FG
    Arch Int Pharmacodyn Ther; 1972 Dec; 200(2):405-14. PubMed ID: 4566854
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemical and pharmacological classification of neuroleptics.
    Janssen PA
    Mod Probl Pharmacopsychiatry; 1970; 5():33-44. PubMed ID: 5535847
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological properties of substituted gamma-butyrolactones. I. The effects on the central nervous system.
    Sieroslawska J; Hano J; Sypniewska M; Czarnecki R; Chojnacka-Wójcik E; Harasiewicz A
    Pol J Pharmacol Pharm; 1973; 25(1):1-16. PubMed ID: 4798097
    [No Abstract]   [Full Text] [Related]  

  • 16. The distribution of the butyrophenones haloperidol, trifluperidol, moperone, and clofluperol in rats, and its relationship with their neuroleptic activity.
    Janssen PA; Allewijn FT
    Arzneimittelforschung; 1969 Feb; 19(2):199-208. PubMed ID: 5818759
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological and toxicological studies on gamma-(4-methylpiperidino)-p-fluorobutyrophenone (FG 5111)--a new neuroleptic agent.
    Christensen JA; Hernestam S; Lassen JB; Sterner N
    Acta Pharmacol Toxicol (Copenh); 1965; 23(2):109-32. PubMed ID: 5899275
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroleptic and non-neuroleptic catalepsy.
    Costall B; Naylor RJ
    Arzneimittelforschung; 1973 May; 23(5):674-83. PubMed ID: 4740210
    [No Abstract]   [Full Text] [Related]  

  • 19. The neuroleptics. 3. Pharmacology. Introduction.
    Van Rossum JM; Janssen PA; Boissier JR; Julou L; Loew DM; Moller Nielsen I; Munkvad I; Randrup A; Stille G; Tedeschi DH
    Mod Probl Pharmacopsychiatry; 1970; 5():23-32. PubMed ID: 5527165
    [No Abstract]   [Full Text] [Related]  

  • 20. [Central effects of some adreno- and-or sympatholytic substances. 3. Ptosis, catalepsy, antagonism with respect to apomorphine and amphetamine].
    Boissier JR; Simon P; Giudicelli JF
    Arch Int Pharmacodyn Ther; 1968 Jan; 171(1):68-80. PubMed ID: 5689547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.